https://www.selleckchem.com/pr....oducts/alkbh5-inhibi
ared to PET alone. Conclusion Reductions to the lowest recommended pediatric dosing regimens are possible when using PET/MR. Data suggests that administered dose can be decreased to 2.6 MBq/kg, a 30% reduction in PET activity leading to a corresponding reduction in absorbed dose.Objective The purpose of this investigation was to review our experience with our "Comprehensive Gastrointestinal Transit Study" in the first 229 patients. This scintigraphic study analyzes motility of the entire gut, from esophagus through the rectos
Like
Comment
Share
